Mischief Managed of Blueyonder sat in a shelter in Parkville, MD with a very uncertain future ahead of the little kitten. It was a lucky day when her luminous amber eyes caught the attention of...

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that...

Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop and commercialize novel flavor ingredients for the food, beverage and flavor...

Boston Scientific Corporation (NYSE: BSX) will participate in the Morgan Stanley Global Healthcare Conference on September 13, in New York City. Mike Mahoney, chief executive officer, and Dan...

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that...

VMworld 2016 – QLogic®, a wholly owned subsidiary of Cavium, Inc. (NASDAQ: CAVM) to showcase multiple virtualization and flash storage technologies at VMworld 2016 in QLogic booth 654, Brocade...

Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September...

Centene Corporation (NYSE: CNC) announced today it will present at the Morgan Stanley Global Healthcare Conference, to be held September 12-14, 2016, at the Grand Hyatt Hotel in New York City....

Array BioPharma (Nasdaq: ARRY) announced today results from a Phase 2 study of ARRY-797, an oral, selective p38 mitogen-activated protein kinase inhibitor, in patients with lamin A/C-related...

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference...